U.S. Banks Stock News

Farmers National Banc (FMNB) just wrapped up FY 2025 with fourth quarter revenue of US$46.8 million and EPS of US$0.39, alongside trailing twelve month revenue of US$181.5 million and EPS of US$1.46. Over the last few quarters, the bank has seen revenue move from US$37.2 million in Q3 2024 to US$43.9 million in Q4 2024 and then US$46.8 million in Q4 2025, while quarterly EPS shifted from US$0.23 to US$0.38 and then US$0.39. This has set up a results season in which investors are likely to...

If you are wondering whether Ameren's share price still lines up with its underlying value, or if the recent run leaves limited room for upside, this article is aimed at helping you frame that question clearly. Ameren shares last closed at US$103.58, with a 7 day return of a 0.5% decline, a 30 day return of 3.3%, a year to date return of 2.7%, and a 1 year return of 14.9%, alongside 3 year and 5 year returns of 30.4% and 64.9% respectively. These moves sit against a backdrop where utilities...

Western Alliance Bancorporation (WAL) has capped FY 2025 with fourth quarter total revenue of US$907.9 million and basic EPS of US$2.61, set against trailing twelve month revenue of US$3.3 billion and EPS of US$8.79. Over recent quarters, the bank has seen total revenue move from US$746.8 million in Q1 2025 to US$907.9 million in Q4 2025, while quarterly basic EPS has shifted from US$1.80 to US$2.61 across the same period. This gives investors a clearer line of sight on how earnings are...

California BanCorp (BCAL) has just wrapped up FY 2025 with fourth quarter total revenue of US$50.3 million and basic EPS of US$0.51, while on a trailing twelve month basis revenue was US$189 million and EPS came in at US$1.95. Over the past year, the company has seen revenue move from US$105.7 million to US$189 million and EPS shift from US$0.22 to US$1.95 on a trailing basis, alongside a net profit margin that moved to 33.4% from 5.1%. This puts investor attention squarely on the quality and...

NasdaqGS:NDAQ has amended its corporate charter to allow limited officer exculpation. The change became effective in January 2026 after approval by the US Securities and Exchange Commission. The update affects how Nasdaq's officers are legally protected in connection with corporate decisions. NasdaqGS:NDAQ operates one of the major US securities exchanges and a suite of market technology, data, and listing services used by issuers and investors worldwide. Governance decisions at the holding...

MSCI (MSCI) just posted its latest FY 2025 numbers with Q3 revenue of US$793.4 million and basic EPS of US$4.26, alongside a trailing twelve month net margin of 40% compared with 43.1% a year earlier. The company has seen quarterly revenue move from US$707.9 million in Q2 2024 to US$793.4 million in Q3 2025, while basic EPS has gone from US$3.37 to US$4.26 over the same stretch. This sets the backdrop for investors who are tracking how profit margins are holding up. Given the combination of...

Sysco (SYY) has put up another quarter of solid scale, with Q2 2026 revenue of about US$20.8b, basic EPS of US$0.81 and net income excluding extra items of US$389m, while the trailing twelve months show revenue of roughly US$82.6b, EPS of US$3.73 and net income of US$1.80b. Over the last six reported quarters, revenue has ranged between about US$19.6b and US$21.1b, while quarterly EPS has moved between roughly US$0.81 and US$1.10. This sets the backdrop for a story that hinges on how much...

CNB Financial (CCNE) just posted fourth quarter FY 2025 revenue of US$101.9 million and basic EPS of US$1.10, capping off a trailing twelve month run of US$273.3 million in revenue and US$2.50 in EPS that reflects 23.9% earnings growth over the past year. Over that same twelve month stretch, net income reached US$61.4 million, and the bank paired a 3.65% net interest margin with a 61.49% cost to income ratio. Taken together, these figures offer a clear view of how efficiently the bank is...

Lennox International (LII) has put another solid quarter on the board for FY 2025, with Q3 revenue of US$1.4 billion, basic EPS of US$7.00 and net income of US$245.8 million setting the tone for this earnings season update. The company has seen quarterly revenue move from US$1.5 billion in Q2 2025 to US$1.4 billion in Q3, while EPS has shifted from US$7.86 to US$7.00 over the same stretch. This gives investors a clean read on how the top and bottom line are tracking through the year. With...

Madrigal Pharmaceuticals recently reported that its liver disease drug Rezdiffra has reached over US$1.00 billion in annualized sales, while also signing an exclusive global license agreement with Pfizer for ervogastat, a clinical-stage DGAT-2 inhibitor to expand its MASH treatment pipeline. This combination of rapid commercial uptake for Rezdiffra and external pipeline expansion with Pfizer highlights how Madrigal is trying to build a broader franchise in liver disease treatments. We’ll now...

Otis Worldwide (OTIS) opened FY 2025 with third quarter revenue of US$3.7b and basic EPS of US$0.96, alongside trailing 12 month revenue of US$14.3b and EPS of US$3.41 that frame how the latest print fits into the year so far. The company has seen quarterly revenue move from US$3.6b in Q3 2024 to US$3.7b in Q3 2025, while basic EPS shifted from US$1.35 to US$0.96 over the same period. This sets up a picture where top line scale holds steady, and margins do more of the talking for...

Enova International's FY 2025 Earnings Snapshot Enova International (ENVA) has capped FY 2025 with fourth quarter revenue of US$412.9 million and basic EPS of US$3.19, while trailing twelve month EPS sits at US$12.25 on revenue of about US$1.5 billion. The company has seen quarterly revenue move from US$323.5 million in Q3 2024 to US$412.9 million in Q4 2025, with basic EPS over that stretch ranging from US$1.64 to just above US$3 per share. With net margin at 20.7% over the last year versus...

Starbucks (SBUX) opened fiscal Q1 2026 with revenue of US$9.9b and basic EPS of US$0.26, alongside net income of US$293.3m, setting the tone for how investors assess the latest quarter against a year of softer profitability. Over the past year, the company has seen quarterly revenue range from US$8.8b to US$9.6b and EPS move between US$0.12 and US$0.69, while trailing twelve month figures sit at US$37.7b of revenue, EPS of US$1.20 and net income of US$1.37b. With the trailing net margin at 5%...

John Marshall Bancorp (JMSB) just turned in another steady quarter for FY 2025, with Q3 revenue of about US$15.9 million and basic EPS of roughly US$0.38 on net income of US$5.4 million. The bank has seen revenue move from US$13.4 million and EPS of about US$0.30 in Q3 2024 to US$15.9 million and EPS of roughly US$0.38 in Q3 2025. Trailing 12 month EPS sits around US$1.41 on net income of about US$20.0 million, which highlights a story where higher earnings and firmer profitability metrics...

Taysha Gene Therapies recently reported progress in its TSHA-102 gene therapy program for Rett syndrome, including dosing the first patient in the pivotal REVEAL trial and securing FDA alignment on the study design, while senior executives disclosed significant insider stock sales. This combination of clinical and regulatory milestones with insider activity offers a rare window into both the program’s momentum and leadership’s capital decisions. We’ll now examine how the FDA’s alignment on...

NVR (NVR) has just posted its FY 2025 third quarter numbers, with revenue of US$2.6b and basic EPS of US$119.26, set against a trailing 12 month EPS of US$484.98 and revenue of US$10.6b. Over recent quarters, revenue has moved from US$2.6b in Q2 2025 and US$2.4b in Q1 2025, alongside basic EPS of US$114.52 and US$100.41 respectively. This gives investors a clear read on the run rate as they weigh the latest figures against a net profit margin that has eased from 15.9% to 13.5% over the past...

Orrstown Financial Services (ORRF) has rounded out FY 2025 with fourth quarter revenue of US$64.8 million and basic EPS of US$1.12, alongside trailing twelve month revenue of US$252.1 million and EPS of US$4.21. Over the last few quarters, revenue has moved from US$60.1 million in Q4 2024 to US$64.8 million in Q4 2025, while quarterly basic EPS has shifted from US$0.72 to US$1.12 over the same period. This frames a year in which trailing net income reached US$80.9 million. With a trailing net...

German American Bancorp (GABC) just posted its FY 2025 fourth quarter numbers, reporting revenue of US$94.0 million and EPS of US$0.95, supported by quarterly net income of US$35.7 million. The bank’s revenue moved from US$64.5 million in Q4 2024 to US$94.0 million in Q4 2025, while quarterly EPS increased from US$0.78 to US$0.95 over the same period, indicating a notably different earnings profile than a year ago. With a trailing 12 month net profit margin of 32% and a P/E above sector...

Brinker International (EAT) just posted Q2 2026 results with revenue of US$1.35 billion and basic EPS of US$2.23, alongside net income of US$99.5 million, setting the tone for how its restaurant footprint and sales trends are feeding into profitability. The company has seen quarterly revenue move from US$1.36 billion in Q2 2025 to US$1.43 billion in Q3 2025 and US$1.46 billion in Q4 2025, while basic EPS over that stretch ran from US$2.67 in Q2 2025 to US$2.68 in Q3 2025 and US$2.40 in Q4...

Teva Pharmaceutical Industries (NYSE:TEVA) has just posted its FY 2025 third quarter numbers, with revenue of US$4.5b and basic EPS of US$0.38, as the trailing 12 month line shows revenue of US$16.8b and basic EPS of US$0.62. Over recent quarters the company has seen revenue range from US$4.2b in Q4 2024 to US$4.5b in Q3 2025, while basic EPS moved from a loss of US$0.19 in Q4 2024 to a profit of US$0.38 in Q3 2025. This sets up a story where margin trends and the mix of products in late...

Polaris (PII) closed out FY 2025 with Q4 revenue of US$1.9b and a basic EPS loss of US$5.34, as net income excluding extra items came in at a loss of US$303.6m. Over recent quarters the company has seen revenue move from US$1.6b in Q1 2025 to US$1.9b in Q4 2025. Basic EPS shifted from a loss of US$1.17 in Q1 to a larger loss of US$5.34 in Q4, with trailing twelve month EPS at a loss of US$8.18 on US$7.2b of revenue. For investors, the headline takeaway is that top line scale sits against...

UP Fintech Holding recently drew increased attention as analysts raised earnings estimates and assigned it a favorable ranking based on those revised expectations. At the same time, options markets showed an unusually strong tilt toward calls and higher implied volatility, underscoring intensified positioning ahead of the company’s March earnings release, which has now passed. We’ll now examine how this surge in bullish options activity shapes UP Fintech Holding’s investment narrative for...

Lakeland Financial (LKFN) closed out FY 2025 with fourth quarter revenue of US$69.8 million and basic EPS of US$1.17, alongside trailing twelve month EPS of US$4.02. Over the past year, total revenue has moved from US$236.8 million on a trailing basis at the end of 2024 to US$257.2 million by the fourth quarter of 2025, while quarterly EPS shifted from US$0.94 in Q4 2024 to US$1.17 in Q4 2025. This gives investors a clear view of how the income line is tracking into the new year. With a...

Why Waters (WAT) is on investors’ radar today Waters (WAT) has been drawing attention after recent share price moves, with the stock roughly flat over the past month but showing a gain over the past 3 months and mixed longer term returns. See our latest analysis for Waters. Recent trading has cooled slightly, with a 7 day share price return of 2.94% and a 1 day move of a 1.30% decline. However, the 90 day share price return of 12.29% contrasts with a 1 year total shareholder return of a 4.74%...